Would you consider continuing a biologic for difficult to control autoimmune disease in a patient with a recent diagnosis of a surgically curable solid malignancy?

Topics: Radiation Oncology • Medical Oncology • Rheumatology • General Rheumatology

Would you favor the use of any particular biologics over others?

Answer from: at Academic Institution

There continues to be relative uncertainty regarding the management of biologic therapy in these patients. As treating physicians, this scenario is not uncommon where a decision to continue or stop a biologic has to be made in face of solid malignancy. A detailed review of individual circumstances t...

Comments

at NIAMS
I have lateraled this approach to patients using J...

at NYU Langone
Do you mean using JAK inhibitors instead of TNFi i...

at Baptist Health System
How would your management change if it was Lymphom...

Related Questions